RE:Depreciation/AmortizationI would expect those numbers to be high - especially with this size of the Grupo buy.
The numbers will likely be high for 10 of 15 year - but that's just me guessing.
I think that's why it's important to look at EBITDA on a yoy basis to see if we're moving in the right direction.
With Paladin, we grew very slowly with very small purchases in the first 11-12 years. We got a lot of debt in some smaller purchases and used that debt against our profits.
Even when we moved into Sub-Saharan Africa, it was initially in a small partnership - converted to a larger partnership down the road (never owning more than 44%) and then eventually sold to Endo. Never really made a 100% buy as big as this one. Therefore, effects were less obvious until revenues/earning were growing at a nice clip.
That's sort of how I remember it - was a long time ago.